Kansenshogaku Zasshi最新文献_第6页

A Case of Asymptomatic Toxocariasis Encountered after Enforcement of a Ban on the Ingestion of the Raw Liver of Cows 禁止食用生牛肝后发生无症状弓形虫病1例

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.101

Nanase Watatani, O. Nishiyama, Y. Kunita, A. Sano, H. Sano, Koichi Yoshida, Y. Tohda

引用次数: 0

Monitoring of Adverse Events Associated with COVID-19 Vaccine (Tozinameran) -Influence of Sex, Age, and Number of Doses on the Frequencies of Adverse Reactions- COVID-19疫苗(Tozinameran)相关不良事件的监测——性别、年龄和剂量对不良反应发生频率的影响

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.65

Yasuo Kurata, Noboru Inoue, Satoko Kondo, K. Onozawa, N. Tani, J. Minami, R. Oishi, S. Nagano, H. Araki, H. Kuwano

{"title":"Monitoring of Adverse Events Associated with COVID-19 Vaccine (Tozinameran) -Influence of Sex, Age, and Number of Doses on the Frequencies of Adverse Reactions-","authors":"Yasuo Kurata, Noboru Inoue, Satoko Kondo, K. Onozawa, N. Tani, J. Minami, R. Oishi, S. Nagano, H. Araki, H. Kuwano","doi":"10.11150/kansenshogakuzasshi.96.65","DOIUrl":"https://doi.org/10.11150/kansenshogakuzasshi.96.65","url":null,"abstract":"This study was aimed at monitoring the adverse reactions to tozinameran (mRNA vaccine against SARS-CoV-2) in the vaccine recipients, and to investigate factors that might affect the risk of development of these reactions. The adverse events (13 injection-site and systemic reactions) on day 1 (vaccination day), day 2, day 3, day 4, and day 5- were monitored in the employees of Fukuoka City Hospital who were vaccinated at the hospital between March 2021 and April 2021. The severities of the adverse reactions were also investigated. The frequencies of virtually all the adverse reactions were the highest on day 2, both after the first and after the second dose. The incidence of adverse reactions on day 2 after the first (and second) vaccine dose was 86.0% (86.9%) for pain at the injection site, 33.2% (76.9%) for fatigue, 14.3% (56.9%) for headache, 37.0% (57.2%) for myalgia, 5.2% (51.1%) for fever, and 9.3% (43.9%) for joint pain. The proportion of recipients with any adverse reactions on day 5- was significantly higher after the second dose than after the first dose. The incidence of moderate to severe adverse reactions (except for pain and swelling at the injection site, and rash) was also significantly higher after the second dose. Differences in the incidence of adverse reactions by sex, age, and number of doses were observed. In particular, female sex, age 55 years or under, and second vaccine dose were associated with a significantly increased incidence of fatigue and headache. Female sex and second vaccine dose were identified as being consistently associated with an increased frequency of adverse reactions. The results of the present study would be useful for predicting adverse reactions in prospective recipients, and for setting the vaccination day.","PeriodicalId":17713,"journal":{"name":"Kansenshogaku Zasshi","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87789701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Characteristics of Bacteria Isolated in 2017-2020 from Japanese Companion Animals Using Blood Culture, Compared to Those Isolated in 2014-2016 2017-2020年日本伴侣动物血培养分离的细菌特征与2014-2016年分离的细菌特征比较

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.112

Yuzo Tsuyuki, Yasuto Fukushima, Takashi Takahashi

引用次数: 1

Evaluation of the Clinical Usefulness of Loop-mediated Isothermal Amplification (LAMP) Assay for the Detection of Chlamydia pneumoniae 环介导等温扩增(LAMP)法检测肺炎衣原体的临床应用价值评价

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.74

K. Ouchi, T. Yamazaki, C. Nakahama, S. Yamamoto, N. Tsumura, Y. Sakata, K. Nagai, S. Ikezawa, Toshihiro Tanaka, N. Nishimura, Tetsuya Yamaguchi, A. Nagita, S. Nishimura

引用次数: 0

A Case of Listeria monocytogenes Meningitis in a Man in the Prime of Life with a History of Frequent Consumption of Cheese and Dry-cured Ham 一位经常食用奶酪和干腌火腿的壮年男子患单核细胞增生李斯特菌脑膜炎1例

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.91

Takayuki Yoshioka, Teruki Shin, Hitoshi Kooriyama, T. Ishii, Yoshisuke Haruna, H. Mataki

引用次数: 0

A Case of a Highly Drug-Resistant HIV Detected after Irregular Use of a Self-Prescribed Antiretroviral Drug 不定期使用自开抗逆转录病毒药物后发现高度耐药艾滋病毒1例

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.96

Masahito Oda, Mitsuya Katayama, N. Mori

引用次数: 0

Rate of Colonization and Serotypes of Streptococcus pneumoniae Isolated from Healthy Adult Community Residents after the Regulatory Approval of PPSV23 PPSV23获批后健康社区居民肺炎链球菌的定植率和血清型

Kansenshogaku Zasshi Pub Date : 2022-05-20 DOI: 10.11150/kansenshogakuzasshi.96.82

Yuka Ishihara, T. Yagi, Keigo Shibayama, M. Ohta

引用次数: 0

Safety and Pharmacokinetics of the Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Administered by Intravenous Injection in Japanese and Caucasian Healthy Volunteers 抗sars - cov -2单克隆抗体Sotrovimab在日本和高加索健康志愿者静脉注射的安全性和药代动力学

Kansenshogaku Zasshi Pub Date : 2022-03-20 DOI: 10.11150/kansenshogakuzasshi.96.39

Arisa Okamasa, Malek Okour, D. Austin, Y. Shida, J. Sager, Elizabeth L. Alexander, Dimitra Brintziki, A. Haggag, Stephen Harrison, Takako Hattori, Ian A. Hawes, Nobuhiko Okuda, Scott Segal, A. Skingsley, Robert X Williams, Esther S Yoon, Andrew M. Lippa

引用次数: 1

A Study of Three Pregnant Women Who Gave Birth While Suffering from COVID-19 对三名患有COVID-19的孕妇分娩的研究

Kansenshogaku Zasshi Pub Date : 2022-03-20 DOI: 10.11150/kansenshogakuzasshi.96.46

T. Yokoyama, Haruka Watanabe, Shou Iwasaka, T. Ishimaru

引用次数: 0

Quantitative Measurement of the SARS-CoV-2 IgG Antibody and Surrogate Neutralizing Antibody Responses among mRNA COVID-19 Vaccine-Inoculated Medical Staff in Designated Medical Institutions for Infectious Diseases 传染病定点医疗机构接种mRNA - COVID-19疫苗医务人员SARS-CoV-2 IgG抗体和替代中和抗体反应的定量测定

Kansenshogaku Zasshi Pub Date : 2022-03-20 DOI: 10.11150/kansenshogakuzasshi.96.52

Shintaro Nagashima, Yoshihiro Kitahara, Aya Sugiyama, Mafumi Okimoto, Bunthen E, Serge Ouoba, Ko Ko, T. Takafuta, J. Tanaka

{"title":"Quantitative Measurement of the SARS-CoV-2 IgG Antibody and Surrogate Neutralizing Antibody Responses among mRNA COVID-19 Vaccine-Inoculated Medical Staff in Designated Medical Institutions for Infectious Diseases","authors":"Shintaro Nagashima, Yoshihiro Kitahara, Aya Sugiyama, Mafumi Okimoto, Bunthen E, Serge Ouoba, Ko Ko, T. Takafuta, J. Tanaka","doi":"10.11150/kansenshogakuzasshi.96.52","DOIUrl":"https://doi.org/10.11150/kansenshogakuzasshi.96.52","url":null,"abstract":"This study was aimed at evaluating the changes in the antibody titers and neutralization ability before and after inoculation with an mRNA COVID-19 vaccine (Pfizer, USA) among healthcare professionals (HCPs) in Japan. A total of 221 HCPs were enrolled and their blood samples were collected at three time points: (1) before vaccination, (2) 3 weeks after the first dose, and (3) 3 weeks after the second dose. The titers of anti-SARS-CoV-2 Spike protein IgG antibody were measured in all the samples using VITROS-Anti-SARS-CoV-2 S1 Quant IgG Antibody (CLEIA, Ortho-Clinical Diagnostics, Inc.), and the surrogate Virus Neutralization Test (sVNT) (ELISA, GenScript, USA) was performed in the samples obtained after the vaccination. The anti-SARS-CoV-2 IgG titers were (1) median: 0.16;Interquartile (IQR): 0.10-0.27, (2) median: 250;IQR: 99.5-466 and (3) median: 2,400;IQR: 1,480-3,950, respectively, at the three time-points. Our study also revealed the relationship between the anti-SARS-CoV-2 IgG antibody titer and the antibody neutralization activity.","PeriodicalId":17713,"journal":{"name":"Kansenshogaku Zasshi","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72695561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2